期刊文献+

靶向bcl-2基因短发卡RNA干扰真核质粒表达稳定株筛选和建立 被引量:3

STABLE CELL STRAINS EXPRESSING LOWER bcl-2 GENE WERE ESTABLISED VIA bcl-2 TARGETING SHORT HAIRPIN RNA PLASMID VECTOR
下载PDF
导出
摘要 目的构建针对bcl-2基因的短发卡RNA(shRNA)干扰真核质粒表达载体,转染到bcl-2基因高表达的胃癌细胞株SGC-7901中,并筛选出稳定低表达bcl-2基因的细胞株。方法针对bcl-2基因的mRNA序列设计、合成4对寡核苷酸序列,插入质粒载体pGPH1/GFP/Neo中,经脂质体介导转染SGC-7901细胞。RT-PCR检测bcl-2基因在mRNA水平的变化,MTT法检测bcl-2基因沉默后胃癌SGC-7901细胞的增殖情况。基因沉默效果最好的一组,经G418筛选以得到稳定表达株。结果与对照组相比,转染成功后的细胞bcl-2基因在mRNA水平均显著下降,细胞增殖速度明显降低(t=2.41,P<0.05);并筛选出稳定表达shRNA2质粒的阳性克隆。结论本研究成功利用针对bcl-2基因的shRNA质粒载体筛选出稳定低表达bcl-2基因的SGC-7901细胞,为胃癌的基因治疗研究奠定了基础。 Objective To construct a short, bcl 2 gene-targeting hairpin RNA (shRNA) plasmid vector, which was transfected to high-bcl-2-gene-expressed gastric cancer line SGC-7901, a ceil strain with stable and low bcl 2 gene expression was then screened. Methods Four pairs of oligonucleotide specific for bcl 2 gene were designed, synthesized, and inserted into pGPH1/GFP/Neo plasmids. The vectors were transfected into SGC-7901 cells with lipofectamine. RTPCR was used to detect bel- 2 gene expression and MTT technique employed to detect the proliferation of tumor cells after bcl-2 gene was silenced. Ceils with the strongest inhibition were selected with G418 and the stable cell clones obtained. Results As compared with the control, the mRNA expression of bcl-2 in the transfected cells was significantly suppressed, the rate of cell proliferation was significantly reduced (t=2.41 ,P〈0.05). Conclusion SGC-7901 cell strains, which express stable and lower level of bci-2 mRNA, were successfully obtained by using bcl 2-targeting shRNA plasmid vector. The present study provided basis for research on gene therapy of gastric cancer.
出处 《青岛大学医学院学报》 CAS 2010年第2期95-97,100,共4页 Acta Academiae Medicinae Qingdao Universitatis
关键词 基因 BCL-2 RNA干扰 质粒 genes, bcl-2 RNA interference piasmids
  • 相关文献

参考文献11

  • 1ARMSTRONG R C, AJA T, XIANG J, et al. Fas induced activation of the cell death related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors[J]. Biol Chem, 1996,271:16850-16855. 被引量:1
  • 2FIRE A, XU S, MONTGOMERY M K, et al. Potent and specific genetic interference by double-stranded RNA in Cae nothabditls elegans[J]. Nature, 1998,391 : 808-811. 被引量:1
  • 3FANIDI A, HARRINGTON E A, EVAN G I. Cooperative interaction between C-myc and Bcl-2 proto oncogenes[J]. Nature, 1992,359(6395) : 554-556. 被引量:1
  • 4MARCUCCI G, BYRDJ C, DAI G, et al. Phase Ⅰ and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia[J]. Blood, 2003,101(2) : 425-432. 被引量:1
  • 5WATERS J S, WEBB A, CUNNINGHAM D, et al. Phase Ⅰ clinical and pharmacokinetic study of Bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma[J]. J Clin Oncol, 2000,18(9):1812 -1823. 被引量:1
  • 6周晓彬,纪新强,徐莉.医用统计学软件PPMS 1.5的组成和应用特点[J].齐鲁医学杂志,2009,24(1):29-32. 被引量:297
  • 7HONCKENBERG D M, OLTVAI Z N, YIN X M, et al. Bcl- 2 function in an antioxidant pathway to prevent apoptosis[J]. Cell, 1993,75(2) :241-251. 被引量:1
  • 8WACHECK V, HEERE-RESS E, HALASCHEK-WINER J, et al. Bcl-2 antisense oligonueleotides chemosensitize human gastric cancer in SCID mouse xenotransplantation model[J]. Mol Med, 2001,79 : 587-593. 被引量:1
  • 9KIM R, EMI M, TANABE K, et al. Preclinical evaluation of antisense bcl-2 as a chemosensitizer for patients with gastric carcinoma[J]. Cancer, 2004 ,101:2177- 2186. 被引量:1
  • 10HOLEN T, AMARZGUIOUI M, WIIGER MT, et al. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor [J]. Nuclei Acids Res, 2002, 30(8) : 1757-1766. 被引量:1

二级参考文献3

共引文献296

同被引文献19

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部